Omeros Corp. buy tamam
Start price
21.12.17
/
50%
€17.58
Target price
01.01.19
€29.77
Performance (%)
-42.84%
End price
01.01.19
€10.05
Summary
This prediction ended on 01.01.19 with a price of €10.05. The BUY prediction by tamam for Omeros Corp. performed very badly with a performance of -42.84%. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Omeros Corp. | -10.880% | -10.880% | 32.469% | 306.902% |
| iShares Core DAX® | 0.721% | 4.566% | 24.333% | 64.224% |
| iShares Nasdaq 100 | -0.413% | 1.884% | 8.848% | 107.611% |
| iShares Nikkei 225® | 3.500% | 7.196% | 24.030% | 57.276% |
| iShares S&P 500 | 0.489% | 2.436% | 6.048% | 67.009% |
Comments by tamam for this prediction
In the thread Omeros Corp. diskutieren
tamam stimmt der Buy-Einschätzung von marge zu
tamam stimmt am 21.12.2017 der Buy-Einschätzung von marge, aber mit dem Kursziel 33$ zu.
Überschrift: Orphan drug market support blockbuster potential for OMS721
(Laufzeit überschritten)